Browsing: Commercialization

Dive Brief: Senseonics has struck a deal to retake control of the commercialization and distribution of its implantable continuous glucose…

What You Should Know:  – Senseonics Holdings, a medical technology company specializing in implantable continuous glucose monitoring (CGM) systems, has…

What You Should Know: – EVERSANA and Waltz Health have announced a merger valued at $6B to form a unified…

What You Should Know:  – SetPoint Medical, a company focused on developing innovative therapies for chronic autoimmune diseases secures $140M…